Ligelizumab (anti-IgE) - Primary antibody, specific to IGHE, >95%, high purity, Human IgG1, Antibody of immunoglobulin heavy constant epsilon

Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab175579
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab175579-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$59.90
Ab175579-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$279.90
Ab175579-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$739.90
Ab175579-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,189.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameLigelizumab (anti-IgE) - Primary antibody, specific to IGHE, >95%, high purity, Human IgG1
SynonymsIgh2 antibody; IGHE antibody; IGHEP1 antibody; Immunoglobulin heavy constant epsilon antibody; IgE; immunoglobulin heavy constant epsilon; QGE 031; Anti-IGHE Recombinant Antibody; 利戈组单抗; 利格利珠单抗
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityIGHE
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionAntibody of immunoglobulin heavy constant epsilon
Product Description

Ligelizumab (anti-IgE) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab (anti-IgE) can be used for the research of chronic spontaneous urticarial.

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE26.8 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 185.4 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS1322627-61-1

Images

Ligelizumab (anti-IgE) (Ab175579) - SEC
The purity of Ligelizumab (anti-IgE) (Ab175579) is more than 95% verified by HPLC.

Associated Targets(Human)

IGHE Tclin Immunoglobulin heavy constant epsilon (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
IGHE Tclin Ig epsilon chain C region (0 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0405072Certificate of AnalysisApr 30, 2024 Ab175579
ZJ24F0405071Certificate of AnalysisApr 30, 2024 Ab175579
ZJ24F0405070Certificate of AnalysisApr 30, 2024 Ab175579

Related Documents

References

1. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE et al..  (2011)  Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report..  Allergy,  66  (3): (317-30).  [PMID:21083565]
2. Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, Owen CE, Jones I, Lowe PJ.  (2014)  Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects..  Clin Exp Allergy,  44  (11): (1371-85).  [PMID:25200415]
3. Trischler J, Bottoli I, Janocha R, Heusser C, Jaumont X, Lowe P, Gautier A, Pethe A, Woessner R, Zerwes HG et al..  (2021)  Ligelizumab treatment for severe asthma: learnings from the clinical development programme..  Clin Transl Immunology,  10  (3): (e1255).  [PMID:33747510]
4. Batista FD, Anand S, Presani G, Efremov DG, Burrone OR.  (1996)  The two membrane isoforms of human IgE assemble into functionally distinct B cell antigen receptors..  J Exp Med,  184  (6): (2197-205).  [PMID:8976175]
5. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M.  (1994)  High-affinity IgE receptor on eosinophils is involved in defence against parasites..  Nature,  367  (6459): (183-6).  [PMID:8114916]
6. Zhang, K K, Saxon, A A and Max, E E EE..  (1992)  Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of epsilon heavy chain membrane exons..  The Journal of experimental medicine,    (1):   [PMID:1613458]
7. Pirron, U U, Schlunck, T T, Prinz, J C JC and Rieber, E P EP..  (1990)  IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE..  European journal of immunology,      [PMID:2167225]
8. Padlan, E A EA and Davies, D R DR..  (1986)  A model of the Fc of immunoglobulin E..  Molecular immunology,      [PMID:3796618]
9. Flanagan, J G JG and Rabbitts, T H TH..  (1982)  The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes..  The EMBO journal,      [PMID:6234164]
10. Max, E E EE, Battey, J J, Ney, R R, Kirsch, I R IR and Leder, P P..  (1982)  Duplication and deletion in the human immunoglobulin epsilon genes..  Cell,      [PMID:6288268]
11. Seno, M M and 9 more authors..  (1983)  Molecular cloning and nucleotide sequencing of human immunoglobulin epsilon chain cDNA..  Nucleic acids research,    (11):   [PMID:6300763]
12. Ueda, S S, Nakai, S S, Nishida, Y Y, Hisajima, H H and Honjo, T T..  (1982)  Long terminal repeat-like elements flank a human immunoglobulin epsilon pseudogene that lacks introns..  The EMBO journal,      [PMID:6327276]
13. Kenten, J H JH and 6 more authors..  (1982)  Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:6815656]
14. Vouldoukis, I I and 7 more authors..  (1995)  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen..  Proceedings of the National Academy of Sciences of the United States of America,    (15):   [PMID:7544003]
15. Garman, S C SC, Wurzburg, B A BA, Tarchevskaya, S S SS, Kinet, J P JP and Jardetzky, T S TS..  (2000)  Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha..  Nature,    (20):   [PMID:10917520]
16. Heilig, Roland R and 98 more authors..  (2003)  The DNA sequence and analysis of human chromosome 14..  Nature,    (6):   [PMID:12508121]
17. Hibbert, Richard G RG and 9 more authors..  (2005)  The structure of human CD23 and its interactions with IgE and CD21..  The Journal of experimental medicine,    (19):   [PMID:16172256]
18. Schroeder, Harry W and Cavacini, Lisa..  (2010)  Structure and function of immunoglobulins..  The Journal of allergy and clinical immunology,      [PMID:20176268]
19. McHeyzer-Williams, Michael; Okitsu, Shinji; Wang, Nathaniel and McHeyzer-Williams, Louise..  (2011)  Molecular programming of B cell memory..  Nature reviews. Immunology,    (9):   [PMID:22158414]
20. Joulia, Régis R and 6 more authors..  (2015)  Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence..  Nature communications,    (28):   [PMID:25629393]

Solution Calculators